Prof. Peter Rossing on diabetes complications

suPARnostic See all

Prof. Peter Rossing on diabetes complications

Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)

suPARnostic See all

Jesper Eugen-Olsen presenting how suPAR can be used to predict patient...
Jesper Eugen-Olsen presenting how suPAR can be used to predict patient...
Patients with type 1 diabetes are prone to develop complications such as...

interview on the following publication: 


suPAR ca 1:10
At Copenhagen University Hospital Hvidovre, suPAR is measured as part of the...